Long-term evaluation of dabigatran 150 vs. 110 mg twice a day in patients with non-valvular atrial fibrillation.
暂无分享,去创建一个
S. Yusuf | J. Pogue | M. Ezekowitz | S. Connolly | H. Diener | J. Eikelboom | J. Oldgren | M. Brueckmann | A. Clemens | L. Wallentin | P. Reilly | Judith Spahr | H. Noack | A. Kent